Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 5/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL905471 | 1.00 | ALDH1A1 (0.44) | ALDH1A1TP53FAAHCNR1CNR2 | |
| SCHEMBL10838919 | 0.93 | TP53 (0.45) | ALDH1A1TP53FAAHCNR1CNR2 | |
| SCHEMBL8632043 | 0.91 | TP53 (0.44) | ALDH1A1TP53FAAHCNR1CNR2 | |
| SCHEMBL8843258 | 0.91 | TP53 (0.44) | ALDH1A1TP53FAAHCNR1CNR2 | |
| SCHEMBL1033067 | 0.91 | TP53 (0.44) | ALDH1A1TP53FAAHCNR1CNR2 | |
| SCHEMBL14185392 | 0.91 | TP53 (0.44) | ALDH1A1TP53FAAHCNR1CNR2 | |
| SCHEMBL8843220 | 0.91 | TP53 (0.44) | ALDH1A1TP53FAAHCNR1CNR2 | |
| SCHEMBL8843279 | 0.91 | TP53 (0.44) | ALDH1A1TP53FAAHCNR1CNR2 | |
| SCHEMBL22263512 | 0.91 | TP53 (0.44) | ALDH1A1TP53FAAHCNR1CNR2 | |
| SCHEMBL8844066 | 0.91 | TP53 (0.44) | ALDH1A1TP53FAAHCNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9240614-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2016-01-19 | — | — | US | disclosed |
| EP-2579377-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES (JP) | 2014-09-03 | — | — | EP | disclosed |
| EP-2579377-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | Ube Industries, Ltd. (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-20130071733-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES, LTD. (JP) | 2013-03-21 | — | — | US | disclosed |
| US-7534908-B2 | Method for the production of optically active 3-alkylcarboxylic acids and the intermediate products thereof | WACKER CHEMIE AG (DE) | 2009-05-19 | — | — | US | disclosed |
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2007-09-27 | — | — | US | disclosed |
| CN-1950508-A | Process for producing optically active alcohol and carboxylic acid | API CORP (JP) | 2007-04-18 | — | — | CN | disclosed |
| EP-1748975-A1 | METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE 3-ALKYL CARBOXYLIC ACIDS AND THE INTERMEDIATE PRODUCTS THEREOF | Consortium für elektrochemische Industrie GmbH (DE) | 2007-02-07 | — | — | EP | disclosed |
| US-20060041015-A1 | Use of treosulfan and derivaties thereof for treating multiple sclerosis | MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH (DE) | 2006-02-23 | — | — | US | disclosed |
| WO-2005115955-A1 | METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE 3-ALKYL CARBOXYLIC ACIDS AND THE INTERMEDIATE PRODUCTS THEREOF | Consortium für elektrochemische Industrie GmbH (DE) | 2005-12-08 | — | — | WO | disclosed |
| EP-1528922-A1 | USE OF TREOSULFAN AND DERIVATIVES THEREOF FOR TREATING MULTIPLE SCLEROSIS | Medac Gesellschaft für klinische Spezialpräparate mbH (DE) | 2005-05-11 | — | — | EP | disclosed |
| WO-2004016263-A1 | USE OF TREOSULFAN AND DERIVATIVES THEREOF FOR TREATING MULTIPLE SCLEROSIS | Medac Gesellschaft für klinische Spezialpräparate mbH (DE) | 2004-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | ME1, ME3, ACMSD | ALDH1A1 128/4885TP53 4342/4885FAAH 95/4885 |
| US-20060041015-A1 | Use of treosulfan and derivaties thereof for treating multiple sclerosis | TST, TXNRD3, TXN | ALDH1A1 450/4885TP53 4730/4885FAAH 2843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.